Dynamics of Endothelial Function Impairment in Patients with Initial Poor Compensation of Type 2 Diabetes Mellitus in Correction of Hypertension with Angiotensin II Receptor Antagonists during a year

Authors

  • N.O. Pertseva SI «Dnipropetrovsk Medical Academy of Ministry of Health of Ukraine»

DOI:

https://doi.org/10.22141/2224-0721.7.63.2014.77119

Keywords:

type 2 diabetes mellitus, hypertension, endothelial dysfunction

Abstract

The purpose of this study is to determine the dynamics of endothelial dysfunction intensity in patients with poor compensation of type 2 diabetes mellitus and hypertension treating with angiotensin II receptor antagonists during a year. It was shown that adequate hypoglycemic standard treatment allowed reduce the concentration of glycated hemoglobin level below 8 % in 48.6 % of patients and cause regression of microalbuminuria in 18.6 % of patients, but most patients had progressive endothelial dysfunction with increased concentrations of endothelin 1 and von Willebrand factor on 38.3 % (p < 0.05) and 27.8 % (p < 0.05), respectively versus baseline values, which was many times larger than control values. Hypoglycemic therapy in patients treated with angiotensin II receptor antagonists provided a reduction of glycated hemoglobin level to 7–8 % in 46.5 % of patients, and its normalization in 7.0 % of patients, followed by regression of microalbuminuria in 23.3 % of patients.

Downloads

Download data is not yet available.

References

Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications / P. Martin-Gallan, A. Carrascosa, M. Gussinye, C. Dominguez // Free Rad. Biol. Med. — 2003. — Vol. 34, № 12. — P. 1563-1574.

Ceriello A. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients / A. Ceriello, K. Esposito, L. Piconi // Diabetes. — 2008. — Vol. 13. — P. 1349-1354.

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy / B.M. Brenner, M.E. Cooper, D. De Zeeuw // N. Engl. J. Med. — 2001. — Vol. 345. — P. 861-869.

Epstein M. Diabetes and hypertension: the bad companions / M. Epstein // J. Hypertension. — 1997. — Vol. 15, Suppl. 2. — P. 55-62.

Torimoto K. Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus / K. Torimoto, Y. Okada, H. Mori, Y. Tanaka // Cardiovasc. Diabetol. — 2013. — Vol. 13. — P. 18-24.

Xu J. Molecular insights and therapeutic targets for diabetic endothelial dysfunction / J. Xu, M.N. Zou // Circulation. — 2009. — Vol. 13. — P. 1266-1286.

Published

2022-02-18

How to Cite

Pertseva, N. (2022). Dynamics of Endothelial Function Impairment in Patients with Initial Poor Compensation of Type 2 Diabetes Mellitus in Correction of Hypertension with Angiotensin II Receptor Antagonists during a year. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), (7.63), 13–17. https://doi.org/10.22141/2224-0721.7.63.2014.77119

Issue

Section

Original Researches

Most read articles by the same author(s)